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Introduction. Testicular lymphoma is an aggressive disease with a very poor prognosis. Nasal-type natural killer/T-cell lymphoma
(NKTCL-N) in particular is very uncommon and has a rapidly progressive, fatal course. Case Report. We report a case of primary
NKTCL-N of the testis in a 38-years-oldMiddle Easternman.The patient had a history of primary right testicular tumor diagnosed
at an outside institution as a seminoma and treated with orchiectomy followed by chemo/radiation. On admission, the patient had
an enormous nasal granuloma with blood workup showing pancytopenia and elevated liver function tests due to active hepatitis
B infection. CT scan of the sinuses showed a very large soft tissue mass, and PET scan showed splenomegaly with multiple lymph
node masses in the pelvis and the chest areas. Bone marrow and nasal tumor biopsies as well as review of the slides from the initial
orchiectomy were all in favor of NKTCL-N lymphoma.The patient was treated with CHOD based combination chemotherapy and
responded dramatically to the first two cycles but passed away from fulminant hepatitis B infection. Conclusion. Despite all known
treatments of NKTCL-N lymphoma of the testes, this disease has a very poor prognosis and invariably follows an aggressive clinical
course.
1. Introduction
According to theWorldHealthOrganization (WHO) classifi-
cation of hematolymphoid tumors, there are three categories
of natural killer cell tumors, extranodalNK/T-cell lymphoma,
the nasal type (NKTCL-N), an aggressive NK cell leukemia,
and blastic NK cell lymphoma. The NKTCL-N lymphoma
has two distinct variants, depending on the site of origin
(nasal versus nonnasal) [1]. The Nasal variant occurs mainly
inmidline structures including the nasal cavity, nasopharynx,
and paranasal sinuses, whereas the extranasal one involves
the skin, the gastrointestinal tract, the salivary glands, the
spleen, the lungs, and the testis [1]. Regardless of these
presentations, the WHO classification groups both nasal and
extranasal NKTCL-N lymphoma in the same category as
“nasal type” although they have different clinical manifesta-
tions, treatment approaches, and prognosis [2, 3].
Primary testicular lymphoma (PTL) is a rare disease
accounting for 1% of non-Hodgkin’s lymphomas and is
a potentially fatal disease. Diffuse large B-cell lymphoma
(DLBCL) constitutes more than 70% of testicular lym-
phomas, occurring mostly in the seventh decade and has
an aggressive clinical course [4]. Testicular NKTCL-N lym-
phoma is a very rare entity with an aggressive natural history
with tumors cells expressing CD56. To date there are only 15
reported cases in the literature, and these mainly occurred
in Asians and the Native American populations of Mexico
and Central and South America [5–18]. In this case report
we will report the 16th case of primary testicular NKTCL-N
lymphoma and the first case to be reported in theMiddle East.
2. Case Report
A 38-years-old Middle Eastern man was admitted to our
hospital for the management of a nasal granuloma. He had
a history of primary right testicular tumor diagnosed at an
outside institution as a seminoma and treated with orchiec-
tomy followed by single agent Cisplatin and radiation therapy
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Figure 1: Pictures (a) and (b) showing anterior and lateral views of nasal granuloma from metastatic testicular ENKTCL-N lymphoma.
Pictures (c) and (d) showing a CT of the sinuses with and without contrast, respectively, showing the nasal mass. Note: the patient had
consented for the use of those pictures in research purposes.
to the retroperitoneum. Few months after this diagnosis, the
patient had an SMR procedure for nasal septal deviation.
Shortly after that he developed nasal infection that progressed
gradually into a very large granuloma. Despite a broad
spectrum antibiotic coverage and antifungal therapy given at
that institute, the patient nasal granuloma did not improve
and was then associated with dysphagia and multiple oral
ulcers.
Upon admission to the hospital, physical exam showed a
very large nasal granuloma with swelling of the soft tissues
of the face. In addition, he had necrotized crusty and dis-
colored cutaneous lesions with abundant purulent discharge
(Figure 1). Oral inspection revealed tonsillar, palatine, and
uvular involvement with infected foul smelling discharge.
Also the patient was noted to have obvious bulky inguinal
lymph nodes that were fixed and hard, hepatosplenomegaly,
and left lower extremity edema.
Blood workup showed anemia, thrombocytopenia, and
moderate lymphopenia as confirmed by peripheral smear.
He also had elevated AST/ALT about ten times the normal
upper limit, EBV IgG positive, and HbsAg positive in favor
of active hepatitis B infection. Culture of the nasal swab grew
pseudomonas and Candida. CT scan of the sinuses showed
large 10 cm soft tissue mass in the nose extending into the
nasal cavity and necrotic lesions in the tonsils (Figure 1). PET
scan showed splenomegaly, multiple lymph node masses in
the pelvis, tracheal, and laryngeal walls.
Bone marrow and nasal tumor biopsies revealed dense
and diffuse proliferation of medium to large sized atyp-
ical lymphoid population (Figure 2(a)). The tumor cells
expressed LCA, CD56, and CD3 cytoplasmic and were nega-
tive for CD20 suggestingNKTCL-N lymphoma (Figure 2(b)).
Review of the slides from the initial orchiectomy was also
diagnostic of primary testicular NKTCL-N.
The patient was treated with Imipenem and Caspofungin
for his local superinfection until he improved. He was then
started on Lamivudine and Interferon alpha-2b as a treatment
for hepatitis B prior to discharge from the hospital. Preventive
measures for tumor lysis syndromewere then started, and the
patient was offered a CHOD based combination chemother-
apy. The patient responded dramatically and rapidly to the
first two cycles with repeat CT scan of the total body showing
near total resolution of the lymphadenopathies. He had also
a near total regression of the nasal lesion. Unfortunately, the
patient passed away from fulminant hepatitis B infection.
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Figure 2: Picture (a) showing dense and diffuse polymorphous population of tumor cells consisting of small to medium sized and large cells
with irregular nuclei. Picture (b) showing an immunohistochemistry with tumor cells expressing CD56.
3. Discussion
Primary testicular ENKTCL-N lymphoma is a very rare
disease with only 15 cases reported in the English literature
[5–18]. Those cases were collected through a MEDLINE
search performed from 1965 to 2013 using keywords like
NK T-cell lymphoma, testicular, and nasal type. The average
age of occurrence was 49.4 (ranging from 28 to 76). Eight
of the reported cases were described in Asian people, one
in a Hispanic Columbian and one in a Caucasian French
with the others not identified, consistent with the prevalence
of NKTCL-N lymphoma in those ethnic groups (except for
the Caucasian one) [11]. Among the 15 cases, the disease
relapsed mainly to the contralateral testis and lymph nodes
(5 and 4 cases, resp.) and to a lesser degree to the spleen,
skin, liver, and CNS (3, 3, 2, 2 cases, resp.). Only one of
the patients had his disease relapsed to the nasopharynx
[15]. Almost all patients underwent an orchiectomy and were
treated after that with a CHOP based chemotherapy regimen
and intrathecal Methotrexate followed by radiation therapy.
Despite this multimodality approach, the majority of patients
were deadwithin 6months except for 4whowere alive at 9–14
months but with no further follow-up period reported [11].
This is the first case of primary testicular NKTCL-N in a
Middle Eastern patient to be reported and the second case
identified in a Caucasian patient [11]. It is also the second
reported case to metastasize to the nasal cavity [15]. The
characteristics of the NK/T-cell lymphoma in our patient
were typical including EBV positivity and tissue biopsy
showing dense and diffuse proliferation of medium to large
sized atypical lymphoid population expressing LCA, CD56,
and CD3 cytoplasmic and were negative for CD20 [5–18].
Testicular ENKTCL-N is very uncommon and has a
rapidly progressive, fatal course. The association of EBV
infection contributes to the increased risk, which adversely
affects patient survival [14], suggesting that the presence
of EBV may correlate closely with prognosis in pri-
mary NKTCL-N lymphoma of the testis. Despite intensive
chemotherapy treatments, this disease is highly aggressive
with an early skin, aerodigestive tract, or soft tissue involve-
ment. Almost all patients whose lesions seem to be limited
to the testis relapse within 6 months and die of widespread
dissemination to the skin, CNS,GI tract, or lungwithin 1 year.
4. Conclusion
Primary testicular NKTCL-N is an aggressive type of lym-
phoma with very poor prognosis that invariably follows an
aggressive clinical course irrespective of gender and the kind
of treatments used.
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